Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
RNU6-432P (RNA, U6 small nuclear 432, pseudogene) is classified as a non-coding RNA pseudogene. Pseudogenes like RNU6-432P are genomic DNA sequences similar to known genes but typically lack the regulatory elements and open reading frames required for protein-coding function, rendering them generally non-functional for protein expression. RNU6-432P is part of a larger family of small nuclear RNA pseudogenes derived from the U6 gene, which is involved in splicing as part of the spliceosomal small nuclear ribonucleoproteins (snRNPs) in its functional versions. However, as a pseudogene, RNU6-432P is not known to encode any functional RNA or protein product. While some pseudogenes can exert regulatory effects on their parent genes or participate in competing endogenous RNA (ceRNA) networks, or act as miRNA sponges, the functional and disease relevance of RNU6-432P has not been established in the scientific literature. There are no known drugs targeting this locus, and it is not considered a therapeutic target or biomarker.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on RNA, U6 small nuclear 432, pseudogene (RNU6-432P).